OUR Story
The gap between science and impact is a strategy problem
The name Gabriel is not incidental. It is a declaration. In its deepest meaning, Gabriel represents the messenger, the one who carries truth clearly, arrives with purpose, and creates transformation through clarity. In healthcare strategy, that is precisely the role that has been missing.
Gabriel & Co was founded on a singular conviction: that the gap between scientific excellence and real-world clinical impact is not inevitable. It is the result of three specific failures, in leadership capability, in scientific positioning, and in evidence communication, that compound each other and hold great science back from the patients it was designed to serve.
See how we address each gap: The Three Silos Problem
‘& Co’ is not an afterthought. It is the point. Gabriel & Co is a collective of scientific thinkers, strategy architects, evidence builders, and capability developers who work alongside clients, not above them. Our measure of success is what changes after we leave, not what we delivered while we were there.
Our Vision
A healthcare ecosystem where scientific excellence is never held back by the absence of strategy, story, or leadership.
Our Mission
To empower pharmaceutical, biotech, medical device, and nutraceutical organizations to translate their science into strategic medical insights, high-impact scientific engagements, and shape evidence that drives clinical adoption and sustainable commercial value.
The Gabriel Effect
A Unified System for Healthcare Impact
Most organizations address strategy, evidence, and leadership as three separate problems requiring three separate budgets. They are not separate. They are a system.
Strengthen the leader, and the strategy improves. Improve the strategy and the evidence becomes more purposeful. When the evidence tells a better story, science reaches the patients it was always meant to serve.
This compounding effect – the Gabriel Effect – is why we do not offer isolated services. We offer a unified approach to scientific leadership. Every engagement is designed with all three dimensions in mind, whether we are explicitly addressing all three or not.
1
Leadership
Strong leaders create strategic clarity and organizational direction.
2
Strategy
Better strategy creates focus, positioning, and decision quality.
3
Evidence
Effective evidence builds credibility, confidence, and adoption.
4
Impact
Science reaches patients and creates measurable real-world outcomes.
“The Gabriel Effect recognizes that leadership, strategy, evidence, and impact are not separate challenges. They are one interconnected system.”
Core Values
The principles that guide every engagement, every recommendation, and every outcome.

Clarity
We deliver the clearest possible answer to the most complex questions. No jargon, no hedging, no fifty-slide decks hiding one recommendation. Clarity is a discipline, not a preference.

Authority
We speak with conviction because we have earned the right to, through real-world experience and the willingness
to say things that are true, not just comfortable.

Transformation
We measure success by what changes, not what we deliver. A strategy that sits in a folder is not a strategy. Transformation is the standard we hold ourselves to.
Why India & Why Now
The principles that guide every engagement, every recommendation, and every outcome.
Science Exists
India is home to one of the world’s fastest-growing pharmaceutical, biotech, and MedTech ecosystems.
Talent Exists
The largest pool of English-speaking healthcare graduates and professionals.
Ambition Exists
Organizations are investing heavily in innovation,
growth, and healthcare transformation.
THE MISSING PIECE
Strategic Infrastructure
Medical Affairs capability, evidence generation discipline, and professional development systems that connect scientific excellence to clinical and commercial impact.
Gabriel & Co exists to build that bridge.
Why India & Why Now
India has the science, the talent, and the ambition. Gabriel & Co exists to build the missing strategic infrastructure.
India is the world’s third-largest pharmaceutical market by volume. It is home to one of the fastest-growing biotech sectors globally, a rapidly expanding MedTech industry, and the largest pool of English-speaking healthcare graduates anywhere in the world. The science exists. The talent exists. The commercial ambition exists.
What has been consistently underdeveloped is the strategic infrastructure – the Medical Affairs capability, the evidence generation discipline, and the professional development system that connects scientific excellence to clinical and commercial impact.
Gabriel & Co was built for this intersection. For the organizations that know their science is valuable and cannot afford to have it underperform. And for the professionals who know they belong in strategic healthcare leadership and have never been given a structured path to get there.
